Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.45	6.07	9.29	13.52	15.19	11.67
Short-Term Investments	3.92	8.2	10.49	26.37	45.98	0.02
Cash & Short-Term Investments	9.37	14.27	19.78	39.89	61.16	11.7
Cash Growth	-26.42%	-27.89%	-50.41%	-34.77%	422.83%	-4.58%
Other Receivables	1.1	0.26	0.29	0.46	0.18	0.07
Receivables	1.1	0.26	0.29	0.46	0.18	0.07
Prepaid Expenses	-	1.44	0.75	1.31	1.35	0.07
Restricted Cash	0.15	0.08	0.08	0.08	-	-
Total Current Assets	10.61	16.04	20.9	41.74	62.69	11.84
Property, Plant & Equipment	0.22	0.54	0.7	0.59	0.7	0.58
Other Long-Term Assets	0.3	0.39	0.56	0.73	0.96	0.06
Total Assets	11.13	16.96	22.15	43.06	64.35	12.48
Accounts Payable	0.38	0.67	0.52	1.69	1.34	0.09
Accrued Expenses	1.05	2.44	4.25	4.94	1.21	1.15
Current Portion of Leases	-	0.12	0.08	0.12	0.11	0.07
Total Current Liabilities	1.43	3.22	4.84	6.75	2.65	1.32
Long-Term Leases	-	0.21	0.32	0.09	0.24	0.36
Total Liabilities	1.43	3.43	5.15	6.84	2.89	1.67
Additional Paid-In Capital	117.7	116.16	105.68	101.26	97.64	34.5
Retained Earnings	-108	-102.62	-88.68	-63.82	-36.17	-23.7
Treasury Stock	-	-	-	-1.22	-	-
Total Common Equity	9.7	13.54	17	36.22	61.47	10.8
Shareholders' Equity	9.7	13.54	17	36.22	61.47	10.8
Total Liabilities & Equity	11.13	16.96	22.15	43.06	64.35	12.48
Total Debt	-	0.32	0.39	0.21	0.34	0.43
Net Cash (Debt)	9.37	13.94	19.39	39.68	60.82	11.27
Net Cash Growth	-24.27%	-28.10%	-51.13%	-34.76%	439.64%	-6.58%
Net Cash Per Share	1.68	3.11	6.60	13.95	23.45	6.59
Filing Date Shares Outstanding	5.17	4.71	3.55	2.76	2.85	-
Total Common Shares Outstanding	5.17	4.71	3.55	2.76	2.85	-
Working Capital	9.18	12.82	16.06	34.99	60.04	10.52
Book Value Per Share	1.87	2.87	4.79	13.11	21.56	-
Tangible Book Value	9.7	13.54	17	36.22	61.47	10.8
Tangible Book Value Per Share	1.87	2.87	4.79	13.11	21.56	-
Machinery	-	0.5	0.5	0.5	0.43	0.21
Leasehold Improvements	-	0.01	0.01	0.02	0.02	0.01

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q